Importance

Loading Importance Indicators...

Abstract

The present invention is drawn to delivery systems for administering a therapy to a target tissue or target composition in a mammalian subject, using an ultrasonic energy-activated targeted agent. The claimed energy-activated targeted therapy is useful in the treatment of specifically selected target tissues, such as vascular endothelial tissue, the abnormal vascular walls of tumors, solid tumors of the head and neck, tumors of the gastrointestinal tract, tumors of the liver, tumors of the breast, tumors of the prostate, tumors of the lung, nonsolid tumors, malignant cells of the hematopoietic and lymphoid tissue and other lesions in the vascular system or bone marrow, and tissue or cells related to autoimmune and inflammatory disease.

Loading the Abstract Image...

First Claim